Related references
Note: Only part of the references are listed.Reference Standards for Newborn Screening of Metabolic Disorders by Tandem Mass Spectrometry: A Nationwide Study on Millions of Chinese Neonatal Populations
Falin He et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2021)
Combining newborn metabolic and genetic screening for neonatal intrahepatic cholestasis caused by citrin deficiency
Yiming Lin et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2020)
AGC2 (Citrin) Deficiency-From Recognition of the Disease till Construction of Therapeutic Procedures
Takeyori Saheki et al.
BIOMOLECULES (2020)
Estimating carrier frequencies of newborn screening disorders using a whole-genome reference panel of 3552 Japanese individuals
Yumi Yamaguchi-Kabata et al.
HUMAN GENETICS (2019)
Current treatment for citrin deficiency during NICCD and adaptation/compensation stages: Strategy to prevent CTLN2
Yoshiyuki Okano et al.
MOLECULAR GENETICS AND METABOLISM (2019)
Expanded Newborn Screening for Inborn Errors of Metabolism by Tandem Mass Spectrometry in Suzhou, China: Disease Spectrum, Prevalence, Genetic Characteristics in a Chinese Population
Ting Wang et al.
FRONTIERS IN GENETICS (2019)
Risk factors associated with mortality in neonatal intrahepatic cholestasis caused by citrin deficiency (NICCD) and clinical implications
Kuerbanjiang Abuduxikuer et al.
BMC PEDIATRICS (2019)
Metabolomic Profiling of Plasma Samples from Women with Recurrent Spontaneous Abortion
XiaoCui Li et al.
MEDICAL SCIENCE MONITOR (2018)
Molecular and clinical characterization of citrin deficiency in a cohort of Chinese patients in Hong Kong
S. C. Chong et al.
MOLECULAR GENETICS AND METABOLISM REPORTS (2018)
Biochemical and molecular characteristics of citrin deficiency in Korean children
Seak Hee Oh et al.
JOURNAL OF HUMAN GENETICS (2017)
Medium-chain plasma acylcarnitines, ketone levels, cognition, and gray matter volumes in healthy elderly, mildly cognitively impaired, or Alzheimer's disease subjects
Domenico Ciavardelli et al.
NEUROBIOLOGY OF AGING (2016)
Steatogenesis in adult-onset type II citrullinemia is associated with down-regulation of PPARα
Michiharu Komatsu et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2015)
Citrin deficiency presenting as acute liver failure in an eight-month-old infant
Mei-Hong Zhang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
SLC25A13 Gene Analysis in Citrin Deficiency: Sixteen Novel Mutations in East Asian Patients, and the Mutation Distribution in a Large Pediatric Cohort in China
Yuan-Zong Song et al.
PLOS ONE (2013)
Neonatal intrahepatic cholestasis caused by citrin deficiency: prevalence and SLC25A13 mutations among thai infants
Supom Treepongkaruna et al.
BMC GASTROENTEROLOGY (2012)
Biochemical characteristics of neonatal cholestasis induced by citrin deficiency
Jian-She Wang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2012)
Genotypic and phenotypic features of citrin deficiency: Five-year experience in a Chinese pediatric center
Yuan-Zong Song et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2011)
The biochemical and toxicological significance of hypermethionemia: new insights and clinical relevance
Joseph T. Dever et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2010)
[13C]Methionine Breath Test to Assess Intestinal Failure-Associated Liver Disease
Debora Duro et al.
PEDIATRIC RESEARCH (2010)
Liver transplantation for an infant with neonatal intrahepatic cholestasis caused by citrin deficiency using heterozygote living donor
Takanobu Shigeta et al.
PEDIATRIC TRANSPLANTATION (2010)
Neonatal intrahepatic cholestasis caused by citrin deficiency: Clinical and laboratory investigation of 13 subjects in mainland of China
Y. -Z. Song et al.
DIGESTIVE AND LIVER DISEASE (2009)
Identification of 13 novel mutations including a retrotransposal insertion in SLC25A13 gene and frequency of 30 mutations found in patients with citrin deficiency
Ayako Tabata et al.
JOURNAL OF HUMAN GENETICS (2008)
Clinical pictures of 75 patients with neonatal intrahepatic cholestasis caused by citrin deficiency (NICCD)
T. Ohura et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2007)
Time course of acylcarnitine elevation in neonatal intrahepatic cholestasis caused by citrin deficiency
Ni-Chung Lee et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2006)
Adult-onset type II citrullinemia and idiopathic neonatal hepatitis caused by citrin deficiency: involvement of the aspartate glutamate carrier for urea synthesis and maintenance of the urea cycle
T Saheki et al.
MOLECULAR GENETICS AND METABOLISM (2004)
Pathways and control of ketone body metabolism: on the fringe of lipid biochemistry
T Fukao et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2004)
Screening of nine SLC25A13 mutations: their frequency in patients with citrin deficiency and high carrier rates in Asian populations
K Kobayashi et al.
MOLECULAR GENETICS AND METABOLISM (2003)
Mitochondrial aspartate glutamate carrier (citrin) deficiency as the cause of adult-onset type II citrullinemia (CTLN2) and idiopathic neonatal hepatitis (NICCD)
T Saheki et al.
JOURNAL OF HUMAN GENETICS (2002)
Citrin and aralar1 are Ca2+-stimulated aspartate/glutamate transporters in mitochondria
L Palmieri et al.
EMBO JOURNAL (2001)
Share Paper
